Remimazolam for general anesthesia in a patient with aortic stenosis and severe obesity undergoing transcatheter aortic valve implantation.
Atsushi KainumaAyaka KoyamaMao KinoshitaJun IidaTeiji SawaPublished in: JA clinical reports (2024)
Owing to its pharmacological advantages, remimazolam may be an option for anesthesia induction and maintenance in severely obese patients with unstable circulation.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- weight loss
- aortic valve replacement
- transcatheter aortic valve replacement
- ejection fraction
- metabolic syndrome
- aortic valve
- type diabetes
- left ventricular
- insulin resistance
- adipose tissue
- case report
- bariatric surgery
- coronary artery disease
- high fat diet induced
- weight gain
- early onset
- skeletal muscle
- heart failure